Loading provider…
Loading provider…
Gynecologic Oncology Physician in New York, NY
NPI: 1043211626Primary Practice Location
MOUNT SINAI HOSPITAL
1184 5th Ave, New York, NY
Primary Employer
OB/GYN Department of Mount Sinai
mountsinai.org
HQ Phone
Get MD Stephanie's Phone Numberphone_androidMobile
Get MD Stephanie's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
FL State Medical License
2020
NY State Medical License
1996 - 2026
PA State Medical License
1998 - 2002

American Board of Obstetrics and Gynecology
Obstetrics & Gynecology

American Board of Obstetrics and Gynecology
Gynecologic Oncology
University of Pennsylvania Health System
Fellowship • Gynecologic Oncology
1998 - 2001
UC San Diego School of Medicine
medschool.ucsd.edu
Medical School
Until 1994
New York Presbyterian Hospital (Cornell Campus)
Residency • Obstetrics and Gynecology
1994 - 1998
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 50 | 68 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 45 | 57 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 38 | 67 |
| 4 | 99212Established patient outpatient visit, total time 10-19 minutes | 15 | 35 |
More than a name.
Authors: Stephanie V. Blank, John P. Curtin
Publication Date: 2007-08
Too much of a good thing? Projecting the need for gynecologic oncologists over the next 20 years.
Authors: Laura Havrilesky, Warner Huh, Teresa Boitano
Publication Date: 2024-12
Authors: Bhavana Pothuri, Rachel Sobolev, Leslie Boyd, Sarah Kim, John Curtin, Melissa Frey
Journal: Gynecol Oncol
Publication Date: 2017-05-08
Lead Sponsor: Seagen Inc.
Collaborators: Genmab
Intervention / Treatment: DRUG: tisotumab vedotin
Lead Sponsor: EMD Serono Research & Development Institute, Inc.
Collaborators: Merck KGaA, Darmstadt, Germany
Intervention / Treatment: DRUG: Carboplatin, DRUG: Avelumab, DRUG: M6620
Lead Sponsor: Akeso
Collaborators: Akesobio Australia Pty Ltd
Intervention / Treatment: BIOLOGICAL: AK104